Introducing 5’CapQ
Accelerate Development of mRNA Vaccines
Current vaccine manufacturers measure 5’ capping efficiency using complex chromatographic methods that can take up to 2 days plus additional queue and analysis time.
With InDevR’s easy-to-use VaxArray® Platform, you can now measure 5’ capping efficiency with 5’CapQ. Reduce analytical wait times during mRNA vaccine development and bring essential CQA measurements for mRNA analytics to your laboratory.
- Get Results Faster: Simplify testing with technology optimized to provide highly reproducible results in under 2 hours.
- Analysis at Your Benchtop: Reduce testing bottlenecks by bringing mRNA analytics to your facility.
- Less Expertise Required: Standardize characterization of your mRNA vaccines on an easy-to-use microarray-based platform.
Waiting for the 5’ capping efficiency results from a central laboratory or outsourced partner slows down mRNA vaccine development. In just 90 minutes, the 5’CapQ evaluated mRNA samples that differed by 5% capping ratio and statistically differentiated within 1.5% of expected.
5’CapQ measurement of formulated samples with known percent capping efficiency.
No Charge Sample Feasibility Request
Complete this form to submit samples for feasibility analysis. Up to 4 samples free of charge.*
*Valid until end of Setptember 2024. Max 4 samples per customer.
